| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Vor Biopharma Inc.
13D
VOR · 929033207
|
10.0% |
12/23/2025
Event 12/18/2025
|
||||
| ForGrowth III PA B.V. | 10.0% | |||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10.0% | |||||
| Forbion Growth III Management B.V. | 10.0% | |||||
| Schedule 13G · 4 securities · passive | ||||||
|
Aura Biosciences, Inc.
13G
AURA · 05153U107
|
5.1% |
10/1/2026
Event 9/25/2026
|
||||
| ForGrowth III PA B.V. | 5.1% | |||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 5.1% | |||||
| Forbion Growth III Management B.V. | 5.1% | |||||
|
Crescent Biopharma, Inc.
13G
CBIO · G2545C104
|
6.1% |
12/11/2025
Event 12/8/2025
|
||||
| ForGrowth III PA B.V. | 6.1% | |||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 6.1% | |||||
| Forbion Growth III Management B.V. | 6.1% | |||||
|
Astria Therapeutics, Inc.
13G/A
ATXS · 04635X102
|
0% |
11/14/2025
Event 10/16/2025
|
||||
| ForGrowth III PA B.V. | 0% | |||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 0% | |||||
| Forbion Growth III Management B.V. | 0% | |||||
|
RAPT Therapeutics, Inc.
13G
RAPT · 75382E208
|
7.4% |
10/29/2025
Event 10/23/2025
|
||||
| ForGrowth III PA B.V. | 7.4% | |||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.4% | |||||
| Forbion Growth III Management B.V. | 7.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.